| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.36 | 0.05 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |